Biocon
Biocon's Kiran Mazumdar-Shaw Recognised Among World's Top Inspirational Leaders in BioPharma
Biocon's Syngene International Opened Centre for Advanced Protein Studies
Biocon to Divest 2% Stake in Syngene to Comply with Minimum Public Shareholding
BioCon to Start New R&D Facility and Create 1500 Jobs in Telengana
European Medical Agency to Review Biocon's Anti Cancer Biosimilar Trastuzumab